Kingworld Medicines Group Ltd
HKEX:1110
Kingworld Medicines Group Ltd
Operating Income
Kingworld Medicines Group Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kingworld Medicines Group Ltd
HKEX:1110
|
Operating Income
¥78.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
10%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Operating Income
¥22.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Operating Income
¥8.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Operating Income
¥4.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Operating Income
¥2.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
5%
|
CAGR 10-Years
20%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Operating Income
¥3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
14%
|
See Also
What is Kingworld Medicines Group Ltd's Operating Income?
Operating Income
78.7m
CNY
Based on the financial report for Dec 31, 2023, Kingworld Medicines Group Ltd's Operating Income amounts to 78.7m CNY.
What is Kingworld Medicines Group Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
10%
Over the last year, the Operating Income growth was -2%. The average annual Operating Income growth rates for Kingworld Medicines Group Ltd have been 6% over the past three years , 4% over the past five years , and 10% over the past ten years .